medigraphic.com
SPANISH

Salud Pública de México

Instituto Nacional de Salud Pública
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 3

<< Back Next >>

salud publica mex 2020; 62 (3)

Public health literacy in the face of the Covid-19 pandemic emergency

Lazcano-Ponce E, Alpuche-Aranda C
Full text How to cite this article

Language: Spanish
References: 45
Page: 331-340
PDF size: 589.48 Kb.


Key words:

health literacy, SARS-CoV-2, Covid-19, surveillance, Mexico.

ABSTRACT

Health literacy is the process of obtaining knowledge, motivation and individual competencies to understand and access information, express opinions and make decisions with respect to health promotion and maintenance. This applies in different contexts, environments, and throughout life. This conceptual perspective is very necessary in the face of the SARS-CoV-2 virus emergency. This virus produces the Covid-19 disease, which has become a pandemic of devastating effects not only healthwise, but also, importantly, from an economic, political and social point of view. This essay seeks to establish the scientific evidence-based elements that guide public policies for prevention and control. Some of these elements are: a) epidemiologic intelligence. This includes not only the strategy of public surveillance, but also sentinel and event-based surveillance, as it is impossible to actually identify all positive cases; b) Mitigating measures against the spread of the epidemic, such as social distancing and hygiene, washing hands, quarantine, restricting movement and using masks, among others; c) Measures to suppress transmission when the number of cases is very high, such as strict measures to stay at home; d) strengthening health services ’capacity for medical attention and improving health services’ ability to prevent transmission, including the use of diagnostic tests; e) the development of prophylactic vaccines against Covid-19, as well as the development of therapeutic agents. All of these actions must be rapidly implemented, from a multidisciplinary and multisectorial public health perspective, and they absolutely must also be taken with the community’s participation as shared responsibility. Therefore, public health literacy is needed.


REFERENCES

  1. McKernon E. Fake News and the Public. Harper’s magazine. 1925 [citado abril 2020]. Disponible en: https://harpers.org/archive/1925/10/ fake-news-and-the-public/

  2. Sørensen K, Van den Broucke S, Brand H, Fullam J, Doyle G, Pelikan J, Slonszka Z. Health literacy and public health: A systematic review and integration of definitions and models. BMC Public Health. 2012;12(80):1- 13. https://doi.org/10.1186/1471-2458-12-80

  3. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-54. https://doi. org/10.1016/S0140-6736(20)30251-8

  4. Shu Y, McCauley J. GISAID: Global initiative on sharing all influenza data - from vision to reality. Euro Surveill. 2017;22(13):1-3. https://doi. org/10.2807/1560-7917.ES.2017.22.13.30494

  5. Centers for Disease Control and Prevention. Public Health Surveillance and Data. Atlanta, GA: CDC, 2020 [citado abril 13, 2020]. Disponible en: https://www.cdc.gov/surveillance/index.html

  6. Qualls N, Levitt A, Kanade N, Wright-Jegede N, Dopson S, Biggerstaff M, et al. Community Mitigation Guidelines to Prevent Pandemic Influenza — United States, 2017. MMWR Recomm Rep. 2017; 66(1):1-32. https://doi. org/10.15585/mmwr.rr6601a1

  7. Centers for Disease Control and Prevention. FAQ: Covid-19 Data and Surveillance. Atlanta, GA: CDC, 2020 [citado abril 2020]. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/faq-surveillance.html

  8. Centers for Disease Control and Prevention. Update and interim guidance on outbreak of coronavirus disease 2019 (Covid-19). Atlanta, GA: CDC, 2020 [citado abril 10, 2020]. Disponible en: https://emergency.cdc. gov/han/2020/han00428.asp

  9. Lipsitch M, Hayden FG, Cowling BJ, Leung GM. How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count. Lancet. 2009;374(9696):1209-11.

  10. de Lusignan S, López-Bernal J, Zambon M, Akinyemi O, Amirthalingam G, Andrews N, et al. Emergence of a Novel Coronavirus (Covid-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England. JMIR Public Health Surveill. 2020;6(2):e18606. https://doi. org/10.2196/18606

  11. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (Covid-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020. https://doi.org/10.7326/M20-0504

  12. Bauchner H, Sharfstein J. A bold response to the Covid-19 pandemic: medical students, national service, and public health. JAMA. 2020. https:// doi.org/10.1001/jama.2020.6166

  13. Sanche S, Lin YT, Xu C, Romero-Severson E, Hengartner N, Ke R. High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis. 2020;26(7). https://doi.org/10.3201/ eid2607.200282

  14. Hou C, Chen J, Zhou Y, Hua L, Yuan J, He S, et al. The effectiveness of the quarantine of Wuhan city against the Corona Virus Disease 2019 (Covid-19): well-mixed SEIR model analysis. J Med Virol. 2020. https://doi. org/10.1002/jmv.25827

  15. Organización Panamericana de la Salud, Unidad de Información y Análisis de Salud (HA). Iniciativa Regional de Datos Básicos en Salud; Glosario de Indicadores. Washington DC: OPS, 2015 [citado abril 11, 2020]. Disponible en: www.paho.org/hq/dmdocuments/2015/glosario-spa-2014.pdf

  16. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (Covid-19) outbreak in china: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. https://doi.org/10.1001/ jama.2020.2648

  17. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with Covid-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. https://doi. org/10.1016/S0140-6736(20)30566-3

  18. González-Bautista E, Zavala-Arciniega L, Rivera-Rivera L, Leyva-López A, Natera-Rey G, Reynales-Shigematsu LM. Factores sociales asociados con el consumo de tabaco y alcohol en adolescentes mexicanos de poblaciones menores a 100 000 habitantes. Salud Publica Mex. 2019;61(6):764- 74. https://doi.org/10.21149/10563

  19. Shamah-Levy T, Campos-Nonato I, Cuevas-Nasu L, Hernández-Barrera L, Morales-Ruán MC, Rivera-Dommarco J, Barquera S. Sobrepeso y obesidad en población mexicana en condición de vulnerabilidad. Resultados de la Ensanut 100k. Salud Publica Mex. 2019;61(6):852-65. https://doi. org/10.21149/10585

  20. Villalobos A, Rojas-Martínez R, Aguilar-Salinas CA, Romero-Martínez M, Mendoza-Alvarado LR, Flores-Luna ML, et al. Atención médica y acciones de autocuidado en personas que viven con diabetes, según nivel socioeconómico. Salud Publica Mex. 2019;61(6):876-87. https://doi. org/10.21149/10546

  21. Campos-Nonato I, Hernández-Barrera L, Flores-Coria A, GómezÁlvarez E, Barquera S. Prevalencia, diagnóstico y control de hipertensión arterial en adultos mexicanos en condición de vulnerabilidad. Resultados de la Ensanut 100k. Salud Publica Mex. 2019;61(6):888-97. https://doi. org/10.21149/10574

  22. Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus- 2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring). 2020. https://doi.org/10.1002/oby.22831

  23. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity. 2020;109:102433. https://doi.org/10.1016/j.jaut.2020.102433

  24. Klein SL, Gearhart PJ. Commentary for the Special Issue on ‘Aging and Sex in Immunity’. Cell Immunol. 2020;348:104037. https://doi. org/10.1016/j.cellimm.2019.104037

  25. Mizumoto K, Chowell G. Estimating risk for death from 2019 novel coronavirus disease, China, January-February 2020. Emerg Infect Dis. 2020;26(6). https://doi.org/10.3201/eid2606.200233

  26. World Health Organization. Update 49-SARS case fatality ratio, incubation period. May 7, 2003. Ginebra: WHO, 2020 [citado marzo 21, 2020]. Disponible en: https://www.who.int/csr/sars/archive/2003_05_07a/en/

  27. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-Cov). Ginebra: WHO, 2019 [citado abril 11, 2020]. Disponible en: https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory- syndrome-coronavirus-(mers-cov)

  28. Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a modelbased analysis. Lancet Infect Dis. 2020. https://doi.org/10.1016/S1473- 3099(20)30243-7

  29. Organización Panamericana de la Salud. Directrices de Laboratorio para la Detección y el Diagnóstico de la Infección con el Virus Covid-19. Washinton DC: OPS, 2020 [citado marzo 30, 2020]. Disponible en: https:// www.paho.org/es/documentos/directrices-laboratorio-para-detecciondiagnostico- infeccion-con-virus-Covid-19

  30. National Academies of Sciences, Engineering, and Medicine. Rapid expert consultation on SARS-CoV-2 laboratory testing for the Covid-19 pandemic (April 8, 2020). National Academies of Sciences, Engineering, and Medicine, 2020 [citado abril 10, 2020]. Disponible en: https://www.nap. edu/catalog/25775/rapid-expert-consultation-on-sars-cov-2-laboratorytesting- for-the-Covid-19-pandemic-april-8-2020

  31. Cepheid. Xpert Xpress SARS-CoV-2 has received FDA Emergency Use Authorization. Sunnyvale, CA: Cepheid, 2020 [citado abril 2, 2020]. Disponible en: https://www.cepheid.com/coronavirus

  32. Abbott. Detect Covid-19 in as little as 5 minutes. Abbot, 2020 [citado abril 2, 2020]. Disponible en: https://www.abbott.com/corpnewsroom/ product-and-innovation/detect-Covid-19-in-as-little-as-5-minutes.html

  33. Xu H, Yan L, Qiu C, Jiao B, Chen Y, Tan X, et al. 2020. Analysis and prediction of false negative results for SARS-CoV-2 detection with pharyngeal swab specimen in Covid-19 patients: A retrospective study. medRxiv. 2020. https://doi.org/10.1101/2020.03.26.20043042

  34. Streeck H, Hartmann G, Exner M, Schmid M. Vorläufiges Ergebnis und Schlussfolgerungen der COVID-19 Case-ClusterStudy (Gemeinde Gangelt). Nordrhein-Westfalen: Wir in NRW das landesportal, 2020 [citado abril 11, 2020]. Disponible en: https://www.land.nrw/sites/default/files/ asset/document/zwischenergebnis_covid19_case_study_gangelt_0.pdf

  35. Mount Sinai Developing an “End-to-End” Diagnostics Solution for Covid- 19 That Incorporates Diagnosis, Treatment Selection, and Monitoring of Disease Course. Mounr Sinai, 2020 [citado abril 2020]. Disponible en: https://www.mountsinai.org/about/newsroom/2020/mount-sinai-developing- an-end-to-end-diagnostics-solution-for-Covid-19-that-incorporatesdiagnosis- treatment-selection-and-monitoring-of-disease-course-pr

  36. Ebrahim SH, Ahmed QA, Gozzer E, Schlagenhauf P, Memish ZA. Covid-19 and community mitigation strategies in a pandemic. BMJ. 2020;368:m1066. https://doi.org/10.1136/bmj.m1066

  37. Russell ES, Zheteyeva Y, Gao H, Shi J, Rainey JJ, Thoroughman D, Uzicanin A. Reactive school closure during increased influenza-like illness (ILI) activity in western Kentucky, 2013: a field evaluation of effect on ILI incidence and economic and social consequences for families. Open Forum Infect Dis. 2016;3(3). https://doi.org/10.1093/ofid/ofw113

  38. Gatwood J, Meltzer MI, Messonnier M, Ortega-Sanchez IR, Balkrishnan R, Prosser LA. Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations. Drugs. 2012;72:35-48. https://doi. org/10.2165/11597310-000000000-00000

  39. Lane HJ, Blum N, Fee E. Oliver Wendell Holmes (1809-1894) and Ignaz Philipp Semmelweis (1818-1865): Preventing the Transmission of Puerperal Fever. Am J Public Health. 2010;100(6):1008-9. https://doi.org/10.2105/ AJPH.2009.185363

  40. Jumaa PA. Hand Hygiene: Simple and Complex. Int J Infect Dis. 2005; 9(1):3-14. https://doi.org/10.1016/j.ijid.2004.05.005

  41. Organización Mundial de la Salud. Guía de aplicación de la estrategia multimodal de la OMS para la mejora de la higiene de las manos. Washington DC: OMS, 2009 [citado abril 12, 2020]. Disponible en: https://apps. who.int/iris/bitstream/handle/10665/102536/WHO_IER_PSP_2009.02_ spa.pdf?sequence=1

  42. Edmonds-Wilson SL, Nurinova NI, Zapka CA, Fierer N, Wilson M. Review of human hand microbiome research. J Dermatol Sci. 2015;80(1):3- 12. https://doi.org/10.1016/j.jdermsci.2015.07.006

  43. Centros para el Control y la Prevención de Enfermedades. Sepa más sobre cuándo y cómo lavarse las manos. Atlanta, GA: CDC, 2020 [citado abril 10, 2020]. https://www.cdc.gov/handwashing/esp/when-how-handwashing. html

  44. Stern D, López-Olmedo N, Pérez-Ferrer C, González-Morales R, Canto-Osorio F, Barrientos-Gutiérrez T. Rapid review of the use of community-wide surgical masks and acute respiratory infections. Salud Publica Mex. 2020;62(3):305-16. https://doi.org/10.21149/11379

  45. Leung N, Chu D, Shiu E, Kwok-Hung C, McDevitt JJ, Hau B, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. 2020;26:676-80. https://doi.org/10.1038/s41591-020-0843-2




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

salud publica mex. 2020;62